Promising ROd-cone DYstrophy Gene therapY

Clinical trial NCT05748873 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05748873
Sponsor: SparingVision
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Retinitis Pigmentosa

Start date: 2023-04-12
Primary completion: 2027-02-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.